Alex Aravanis ^Investor

Alex Aravanis is a seasoned Chief Technology Officer with a strong background in research and product development in the biotech industry. With a PhD in Electrical Engineering from Stanford University, he has held key leadership roles at companies like Illumina and GRAIL, Inc. His expertise in high-intensity sequencing and multi-cancer detection has led to groundbreaking publications in top scientific journals. As the CEO of Moonwalk Biosciences and a board member at ONI, Alex continues to drive innovation in the field of genomics. His track record of success and passion for advancing healthcare make him a valuable asset to any organization.